secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001729149-24-000075
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed reports record Q4 revenue $50.7M (+35% YoY); net income up 43%
---------------------------------------------------------------------

- Q4 2023 revenue $50.7M, up 35% from $37.5M in Q4 2022; full-year revenue $183.0M, up 32%.
- Q4 net income $3.5M (+43% YoY); full-year net income $10.2M (+65% YoY), seventh consecutive profitable year.
- Adjusted EBITDA for Q4 $12.8M; full-year record $43.1M.
- Company highlights record quarterly and annual net revenues driven by respiratory care services growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914924000075/0001729149-24-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914924000075/vmd-20240306.htm
  HTML page:      https://secwatch.observer/filing/0001729149-24-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer